Oxford BioMedica PLC (OXB) — Cash Flow Reinvestment Rate
Oxford BioMedica PLC (OXB) has a Cash Flow Reinvestment Rate of 0.64x as of June 2025, reinvesting GBX1.51 Million (capex GBX1.51 Million ) from operating cash flow of GBX2.35 Million. Explore Oxford BioMedica PLC capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Oxford BioMedica PLC Cash Flow Reinvestment Rate (2007–2021)
Historical reinvestment intensity for Oxford BioMedica PLC across 6 annual periods. Also explore Oxford BioMedica PLC assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Oxford BioMedica PLC (2007–2021)
Year-by-year capital reinvestment analysis for Oxford BioMedica PLC. For live market cap and broader valuation context, see OXB market cap overview.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.74x | GBX18.92 Million | GBX25.45 Million | GBX9.46 Million | ▼ -85.4% |
| 2020 | 5.10x | GBX15.88 Million | GBX3.12 Million | GBX13.36 Million | ▲ +299.5% |
| 2018 | 1.28x | GBX16.42 Million | GBX12.87 Million | GBX10.15 Million | ▼ -53.9% |
| 2017 | 2.77x | GBX8.24 Million | GBX2.98 Million | GBX1.97 Million | ▲ +2122.2% |
| 2009 | 0.12x | GBX288.00K | GBX2.31 Million | GBX288.00K | ▲ +39.8% |
| 2007 | 0.09x | GBX421.00K | GBX4.73 Million | GBX421.00K | — |